Comparing Comorbidity Indices to Predict Survival After Pediatric Hematopoietic Stem Cell Transplantation for Nonmalignant Disease

Documenti analoghi

• Soluble Thrombomodulin Is Associated With Endothelial Dysfunction Syndromes After Pediatric Hematopoietic Stem Cell Transplantation
  di: Denise Elbæk Horan, et al.
  Pubblicazione: (2025)
• Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplantation in Children: A Single Pediatric Center Experience
  di: Pauline Mazilier, et al.
  Pubblicazione: (2025)
• Increasing Access to Pediatric Allogeneic Hematopoietic Stem Cell Transplantation in South Africa
  di: Candice Laverne Hendricks, et al.
  Pubblicazione: (2026)
• A PRSZT Registry Analysis of Prognostic Factors Influencing Survival and Relapse Rates After Second Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
  di: Ava Momm, et al.
  Pubblicazione: (2026)
• Procedural Sedation outside the Operating Room in Pediatric Hematopoietic Stem Cell Transplant Patients
  di: Heather Xiao, et al.
  Pubblicazione: (2026)